Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-arm study of ropeginterferon alfa-2b in Japanese patients with polycythemia vera
jRCT2080225099Phase 2Completed
- Sponsor
- PharmaEssentia
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ropeginterferon alfa-2b in polycythemia vera (PV), sponsored by PharmaEssentia. Started Feb 2020; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on jRCT2080225099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225099.